ORBIMED ADVISORS LLC - 29 Apr 2025 SCHEDULE 13D/A Report for Corvus Pharmaceuticals, Inc. Common stock (CRVS)

Filing Manager
ORBIMED ADVISORS LLC
Reporting Manager
ORBIMED ADVISORS LLC
Security
Corvus Pharmaceuticals, Inc. Common stock
Symbol
CRVS
Shares outstanding
70,908,862 shares
Disclosed Ownership
9,785,423 shares
Ownership
14%
Form type
SCHEDULE 13D/A
Filing time
01 May 2025, 21:20:55 UTC
Date of event
29 Apr 2025
Next filing
14 May 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ORBIMED ADVISORS LLC 14% 9,785,423 0 9,785,423 /s/ Carl L. Gordon Carl L. Gordon/Member 0001055951
ORBIMED CAPITAL GP V LLC 14% 9,785,423 0 9,785,423 /s/ Carl L. Gordon Carl L. Gordon/Member of OrbiMed Advisors LLC 0001615374